BBA Hospital Management, CEO, fulfilled several European Management positions in life science (cardiovascular) at companies such as Norian and Baxter (Edwards Life science Division).
BSc. MSc. Chemist, President/COO, entrepreneur in life science, more than 24 years of experience at top management/Managing Director level.
Henk J. C. Meijerink
MSc. CTO, biochemist, developed and patented various technologies, 20 years of experience in setting up life science companies.
Dr. Sjef de Kimpe
PhD. Pharmacologist, Development consultant. Vice-president early drug development at BioMarin.
BSc. Chemist, Project Director, more than 40 years of experience in various life science positions at Solvay Pharmaceuticals in Europe and in the USA.
In addition, CFM Pharma Holding supported by multiple expert consultants with extensive experience in pharmaceutical development and by a strong Advisory Board of experts in their respective fields.
CFM Pharma has entered into partnerships with a number of private investors to raise the funding for the preclinical and Phase I trials conducted so far.
For the funding of the Phase II trials and to commercialize its products, CFM Pharma is open for partnerships with specialized Venture Capitalist, private investors and pharmaceutical companies.